[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Gemtuzumab Ozogamicin (CAS 16320-04-0) Market Research Report 2024

March 2024 | 50 pages | ID: GED8D21A893EN
BAC Reports

US$ 2,200.00 US$ 2,650.00 -17 %
Offer valid until March 31, 2024!

Email Delivery - PDF (on default)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question

Gemtuzumab Ozogamicin (CAS 16320-04-0) Market Research Report 2024 presents comprehensive data on Gemtuzumab Ozogamicin markets globally and regionally (Europe, Asia, North America etc.)

The report includes Gemtuzumab Ozogamicin description, covers its application areas and related patterns. It overviews Gemtuzumab Ozogamicin market, names Gemtuzumab Ozogamicin producers and indicates its suppliers.

Besides, the report provides Gemtuzumab Ozogamicin prices in regional markets.

In addition to the above the report determines Gemtuzumab Ozogamicin consumers in the market.

BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).

We can analyze the following elements for each chemical product in any country or region:

  • capacities and production
  • consumption volume and structure
  • market price trends
  • exports and imports
  • existing technologies
  • feedstock market condition
  • market news digest
  • market forecast.

Gemtuzumab Ozogamicin (CAS 16320-04-0) Market Research Report 2024 can feature:

  • market condition and estimations, market forecast
  • chemical product ranges, trademarks, analogous products, application areas
  • regional and global producers, consumers and traders (including contact details).

1. GEMTUZUMAB OZOGAMICIN (CAS 16320-04-0)

1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. GEMTUZUMAB OZOGAMICIN APPLICATIONS

2.1. Gemtuzumab Ozogamicin application spheres, downstream products

3. GEMTUZUMAB OZOGAMICIN MANUFACTURING METHODS

4. GEMTUZUMAB OZOGAMICIN PATENTS

Abstract
Description
Summary of the invention
Detailed description of the invention

5. GEMTUZUMAB OZOGAMICIN MARKET WORLDWIDE 

5.1. General Gemtuzumab Ozogamicin market situation, trends
5.2. Manufacturers of Gemtuzumab Ozogamicin
- Europe
- Asia
- North America
- Other regions
5.3. Gemtuzumab Ozogamicin suppliers (importers, local distributors)
- Europe
- Asia
- North America
- Other regions
5.4. Gemtuzumab Ozogamicin market forecast

6. GEMTUZUMAB OZOGAMICIN MARKET PRICES

6.1. Gemtuzumab Ozogamicin prices in Europe
6.2. Gemtuzumab Ozogamicin prices in Asia
6.3. Gemtuzumab Ozogamicin prices in North America
6.4. Gemtuzumab Ozogamicin prices in other regions

7. GEMTUZUMAB OZOGAMICIN END-USE SECTOR 

7.1. Gemtuzumab Ozogamicin market by application sphere
7.2. Gemtuzumab Ozogamicin downstream markets trends and prospects

*Please note that Gemtuzumab Ozogamicin (CAS 16320-04-0) Market Research Report 2024 is a half ready publication and contents are subject to change. It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 5-7 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. BAC Reports has information for more than 25,000 different chemicals available but it is impossible to have all reports updated immediately. That is why it takes 5-7 days to update a report after an order is received.

Product Name:Gemtuzumab Ozogamicin
Synonyms:
  • (8S,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
  • 13-beta-Ethyl-17-alpha-ethinyl-17-hydroxy-gona-4,9,11-triene-3-one
  • 13-Ethyl-17-alpha-ethynyl-17-hydroxygon-4,9,11-trien-3-one
  • 13-Ethyl-17-hydroxy-18,19-dinor-17-alpha-pregna-4,9,11-trien-20-yn-3-one
  • Ethylnorgestrienone
CAS#:16320-04-0
Formula:C21H24O2
Molecular Weight:308.41



More Publications